BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 30134798)

  • 41. Targeting of rotavirus VP6 to DEC-205 induces protection against the infection in mice.
    Badillo-Godinez O; Gutierrez-Xicotencatl L; Plett-Torres T; Pedroza-Saavedra A; Gonzalez-Jaimes A; Chihu-Amparan L; Maldonado-Gama M; Espino-Solis G; Bonifaz LC; Esquivel-Guadarrama F
    Vaccine; 2015 Aug; 33(35):4228-37. PubMed ID: 25850020
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevention and treatment of relapsing autoimmune encephalomyelitis with myelin peptide-coupled splenocytes.
    Vandenbark AA; Vainiene M; Ariail K; Miller SD; Offner H
    J Neurosci Res; 1996 Aug; 45(4):430-8. PubMed ID: 8872903
    [TBL] [Abstract][Full Text] [Related]  

  • 43. DNA vaccines encoding DEC205-targeted antigens: immunity or tolerance?
    Niezold T; Storcksdieck Genannt Bonsmann M; Maaske A; Temchura V; Heinecke V; Hannaman D; Buer J; Ehrhardt C; Hansen W; Überla K; Tenbusch M
    Immunology; 2015 Aug; 145(4):519-33. PubMed ID: 25819746
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Degenerate antigen recognition by CD4+ effector T cells in experimental autoimmune encephalomyelitis.
    McRae BL; Karandikar NJ; Miller SD
    J Neuroimmunol; 1997 May; 75(1-2):156-62. PubMed ID: 9143249
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Skin langerin+ dendritic cells transport intradermally injected anti-DEC-205 antibodies but are not essential for subsequent cytotoxic CD8+ T cell responses.
    Flacher V; Tripp CH; Haid B; Kissenpfennig A; Malissen B; Stoitzner P; Idoyaga J; Romani N
    J Immunol; 2012 Mar; 188(5):2146-55. PubMed ID: 22291181
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses.
    Gurer C; Strowig T; Brilot F; Pack M; Trumpfheller C; Arrey F; Park CG; Steinman RM; Münz C
    Blood; 2008 Aug; 112(4):1231-9. PubMed ID: 18519810
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The STING activator c-di-AMP exerts superior adjuvant properties than the formulation poly(I:C)/CpG after subcutaneous vaccination with soluble protein antigen or DEC-205-mediated antigen targeting to dendritic cells.
    Volckmar J; Knop L; Stegemann-Koniszewski S; Schulze K; Ebensen T; Guzmán CA; Bruder D
    Vaccine; 2019 Aug; 37(35):4963-4974. PubMed ID: 31320219
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intravenous transfer of apoptotic cell-treated dendritic cells leads to immune tolerance by blocking Th17 cell activity.
    Zhou F; Lauretti E; di Meco A; Ciric B; Gonnella P; Zhang GX; Rostami A
    Immunobiology; 2013 Aug; 218(8):1069-76. PubMed ID: 23587571
    [TBL] [Abstract][Full Text] [Related]  

  • 49. IFN-β Facilitates Neuroantigen-Dependent Induction of CD25+ FOXP3+ Regulatory T Cells That Suppress Experimental Autoimmune Encephalomyelitis.
    Wang D; Ghosh D; Islam SM; Moorman CD; Thomason AE; Wilkinson DS; Mannie MD
    J Immunol; 2016 Oct; 197(8):2992-3007. PubMed ID: 27619998
    [TBL] [Abstract][Full Text] [Related]  

  • 50. T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.
    Zheng H; Zhang H; Liu F; Qi Y; Jiang H
    Immunol Lett; 2014; 157(1-2):38-44. PubMed ID: 24220208
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen-specific protection of mice from autoimmunity.
    Menges M; Rössner S; Voigtländer C; Schindler H; Kukutsch NA; Bogdan C; Erb K; Schuler G; Lutz MB
    J Exp Med; 2002 Jan; 195(1):15-21. PubMed ID: 11781361
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Single chain antibody fragments for the selective targeting of antigens to dendritic cells.
    Demangel C; Zhou J; Choo AB; Shoebridge G; Halliday GM; Britton WJ
    Mol Immunol; 2005 May; 42(8):979-85. PubMed ID: 15829289
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Targeting of antigens to activated dendritic cells in vivo cures metastatic melanoma in mice.
    Mahnke K; Qian Y; Fondel S; Brueck J; Becker C; Enk AH
    Cancer Res; 2005 Aug; 65(15):7007-12. PubMed ID: 16061687
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vaccination with filamentous bacteriophages targeting DEC-205 induces DC maturation and potent anti-tumor T-cell responses in the absence of adjuvants.
    Sartorius R; Bettua C; D'Apice L; Caivano A; Trovato M; Russo D; Zanoni I; Granucci F; Mascolo D; Barba P; Del Pozzo G; De Berardinis P
    Eur J Immunol; 2011 Sep; 41(9):2573-84. PubMed ID: 21688262
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of relapsing autoimmune encephalomyelitis with T cell receptor V beta-specific antibodies when proteolipid protein is the autoantigen.
    Whitham RH; Wingett D; Wineman J; Mass M; Wegmann K; Vandenbark A; Offner H
    J Neurosci Res; 1996 Jul; 45(2):104-16. PubMed ID: 8843028
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combination of apoptotic T cell induction and self-peptide administration for therapy of experimental autoimmune encephalomyelitis.
    Kasagi S; Wang D; Zhang P; Zanvit P; Chen H; Zhang D; Li J; Che L; Maruyama T; Nakatsukasa H; Wu R; Jin W; Sun L; Chen W
    EBioMedicine; 2019 Jun; 44():50-59. PubMed ID: 31097410
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CD4+ T cell expressed CD80 regulates central nervous system effector function and survival during experimental autoimmune encephalomyelitis.
    Podojil JR; Kohm AP; Miller SD
    J Immunol; 2006 Sep; 177(5):2948-58. PubMed ID: 16920930
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of CTLA-4 in induction and maintenance of peripheral T cell tolerance.
    Eagar TN; Karandikar NJ; Bluestone JA; Miller SD
    Eur J Immunol; 2002 Apr; 32(4):972-81. PubMed ID: 11920563
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo.
    Hawiger D; Inaba K; Dorsett Y; Guo M; Mahnke K; Rivera M; Ravetch JV; Steinman RM; Nussenzweig MC
    J Exp Med; 2001 Sep; 194(6):769-79. PubMed ID: 11560993
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Simultaneous induction of CD4 T cell tolerance and CD8 T cell immunity by semimature dendritic cells.
    Kleindienst P; Wiethe C; Lutz MB; Brocker T
    J Immunol; 2005 Apr; 174(7):3941-7. PubMed ID: 15778350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.